STRN3 and neoplasm: We identified AGC kinases and, in particular, novel PKCs (nPKCs), which are known promoters of tumorigenesis54, as downstream effectors of MAP4K and STRN3 in invasion control, complementing previous reports of tumor invasion control by STRIPAK with mechanistic insight26,55.